drugset / Trial / NCT01685671
Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers
Phase 1
Completed
34 enrolled
Chong Kun Dang Pharmaceutical
Seoul National University Hospital · collab
RandomizedCrossoverDouble-blindTreatment
Summary
The purpose of this study is to investigate the pharmacokinetics of CKD-11101 and NESP after SC administration in health male volunteers
Timeline
- Start
- 2012-10-26
- Primary completion
- 2012-12-25
- Completion
- 2013-01-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Darbepoetin alfa | Protein / enzyme biologic | 60 ug | Subcutaneous |